Medicare Enrolled

Dr. Vinay Reddy, MD

Rheumatology · Venice, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
411 COMMERCIAL CT STE C, Venice, FL 34292
8133335080
In practice since 2005 (20 years)
NPI: 1275535536 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Reddy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reddy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Reddy

Dr. Vinay Reddy is a rheumatology in Venice, FL, with 20 years in practice. Based on federal Medicare data, Dr. Reddy performed 111,332 Medicare services across 1,620 unique beneficiaries.

Between the years covered by Open Payments, Dr. Reddy received a total of $62,218 from 59 pharmaceutical and/or device companies across 1670 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Reddy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 23% volume in FL$ $62,218 industry payments

Medicare Practice Summary

Medicare Utilization ↗
111,332
Medicare services
Top 23% in FL for rheumatology
1,620
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,567 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)72,400$4$11
Abatacept infusion (Orencia)26,225$33$85
Golimumab infusion (Simponi Aria)9,250$10$25
Office visit, established patient (20-29 min)1,111$56$184
Measurement of antibody for assessment of autoimmune disorder, any method434$17$50
Administration of chemotherapy into vein, 1 hour or less425$87$345
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle398$50$189
Analysis of substance using immunoassay technique, multiple step method172$11$32
Vitamin D level test113$29$80
New patient office visit (45-59 min)93$113$415
Measurement of antibody for rheumatoid arthritis assessment90$13$36
Rheumatoid factor level89$6$40
Tuberculosis test, gamma interferon81$60$100
Measurement of dna antibody, native or double stranded65$13$100
Measurement of dna antibody, single stranded65$12$50
Office visit, established patient (30-39 min)64$91$270
Injection, methylprednisolone acetate, 80 mg60$9$40
Injection, methylprednisolone acetate, 40 mg49$6$30
New patient office visit (30-44 min)42$63$273
Aspiration and/or injection of fluid from medium joint40$39$145
Joint injection, major joint39$43$175
Office visit, established patient (10-19 min)27$37$110
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
31.9% high complexity
65.9% medium
2.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$62,218
Total received (2018-2024)
Avg $8,888/year across 7 years
Top 10% in FL for rheumatology
59
Companies
1,670
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$26,668 (42.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,298 (40.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,252 (16.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,816
2023
$4,395
2022
$9,518
2021
$3,498
2020
$4,815
2019
$18,554
2018
$16,623

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Horizon Therapeutics plc
$14,540
GENZYME CORPORATION
$9,782
Horizon Pharma plc
$9,300
Aurinia Pharma U.S., Inc.
$3,756
ABBVIE INC.
$2,738
Amgen Inc.
$2,603
Janssen Biotech, Inc.
$2,032
UCB, Inc.
$1,783
Mallinckrodt Hospital Products Inc.
$1,695
PFIZER INC.
$1,533
Novartis Pharmaceuticals Corporation
$1,395
E.R. Squibb & Sons, L.L.C.
$1,227
GlaxoSmithKline, LLC.
$1,167
AbbVie Inc.
$1,013
Mallinckrodt Enterprises LLC
$994
AbbVie, Inc.
$800
Lilly USA, LLC
$788
ANI Pharmaceuticals, Inc.
$683
Genentech USA, Inc.
$567
Exeltis, USA Inc.
$327
Boehringer Ingelheim Pharmaceuticals, Inc.
$319
MEDAC PHARMA, INC.
$278
Flexion Therapeutics, Inc.
$251
Celgene Corporation
$221
Antares Pharma, Inc.
$218
Actelion Pharmaceuticals US, Inc.
$198
AstraZeneca Pharmaceuticals LP
$197
Fresenius Kabi USA, LLC
$172
Radius Health, Inc.
$165
Mallinckrodt LLC
$147
Merck Sharp & Dohme Corporation
$147
Boston Scientific Corporation
$125
TerSera Therapeutics LLC
$102
Otsuka America Pharmaceutical, Inc.
$100
MEDEXUS PHARMA, INC.
$84
Alexion Pharmaceuticals, Inc.
$84
Pacira Therapeutics, Inc.
$72
Bioventus LLC
$69
SANOFI-AVENTIS U.S. LLC
$65
Organon LLC
$48
Hikma Pharmaceuticals USA
$48
Ultragenyx Pharmaceutical Inc.
$41
ASSERTIO THERAPEUTICS, Inc.
$38
DePuy Synthes Sales Inc.
$33
Sebela Pharmaceuticals Inc.
$32
Mission Pharmacal Company
$24
Midatech Pharma US Inc
$24
SOBI, INC
$22
Eisai Inc.
$21
West-Ward Pharmaceuticals
$18
Sandoz Inc.
$18
Takeda Pharmaceuticals U.S.A., Inc.
$18
Orthogenrx Inc.
$17
Novo Nordisk Inc
$15
Purdue Pharma L.P.
$15
SCILEX PHARMACEUTICALS INC.
$14
Zyla Life Sciences, Inc.
$13
Ironwood Pharmaceuticals, Inc
$13
Daiichi Sankyo Inc.
$11
Top 3 companies account for 54.0% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Aquoral · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DUEXIS · DUZALLO · Dayvigo · Durolane · EVENITY · EVUSHELD · Enbrel · FLECTOR · FORTEO · Gralise · HUMIRA · HYRIMOZ · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · Mitigare · Morphabond ER · NO PRODUCT DISCUSSED · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENCIA · Otezla · Otrexup · PANZYGA · PENNSAID · PURIFIED CORTROPHIN GEL · Quzyttir · RAYOS · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RIDAURA · RINVOQ · Rasuvo · Repatha · Rinvoq · Rituxan · SAMSCA · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · STRENSIQ · SYMPROIC · TALTZ · TAVNEOS · TREMFYA · Tavneos · TriVisc sodium hyaluronate · Tymlos · ULTOMIRIS · UPTRAVI · Uloric · VIMOVO · VRAYLAR · Victoza · WATCHMAN Access System · XELJANZ · XYOSTED · ZTLido · Zilretta · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (43%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for rheumatology in FL.

Equivalent to $56 per 100 Medicare services performed
Looking for a rheumatology in Venice?
Compare rheumatologys in the Venice area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
24
Per 100K population
5.3
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL - VENICE
6.4 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Reddy is a mixed practice specialist, with above-average Medicare volume (top 23% in FL), and high industry engagement (speaking/promotional, top 10%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Reddy experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Reddy performed 72,400 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reddy receive payments from pharmaceutical companies?
Yes. Dr. Reddy received a total of $62,218 from 59 companies across 1,670 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reddy's costs compare to other rheumatologys in Venice?
Dr. Reddy's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reddy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →